PAPER Health Quality Ontario
SEARCH RESULTS
331009 RESULTS
PAPER Hernandez-Rapp J, Martin-Lannerée S, Hirsch TZ, Launay JM, Mouillet-Richard S
Hijacking PrP(c)-dependent signal transduction: when prions impair Aβ clearance.
Front Aging Neurosci. 2014;6:25. Epub 2014 Feb 28 PubMed: 24592237PAPER Barbato C, Pezzola S, Caggiano C, Antonelli M, Frisone P, Ciotti MT, Ruberti F
A lentiviral sponge for miR-101 regulates RanBP9 expression and amyloid precursor protein metabolism in hippocampal neurons.
Front Cell Neurosci. 2014;8:37. Epub 2014 Feb 13 PubMed: 24592211PAPER Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM
Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease.
Neuropsychiatr Dis Treat. 2014;10:391-401. Epub 2014 Feb 21 PubMed: 24591834PAPER Matlack KE, Tardiff DF, Narayan P, Hamamichi S, Caldwell KA, Caldwell GA, Lindquist S
Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity.
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4013-8. Epub 2014 Mar 3 PubMed: 24591589PAPER Modh RP, Kumar SP, Jasrai YT, Chikhalia KH
Design, synthesis, biological evaluation, and molecular modeling of coumarin-piperazine derivatives as acetylcholinesterase inhibitors.
Arch Pharm (Weinheim). 2013 Nov;346(11):793-804. Epub 2013 Oct 8 PubMed: 24591157PAPER Yi R, Zhan XR, Tang J, Zhang LM, Liu XM, Dong Q
EEG Synchronization Evaluation: A New Diagnostic Tool for Predicting the Progression of Alzheimer's disease.
Clin EEG Neurosci. 2015 Apr;46(2):130-5. Epub 2014 Mar 3 PubMed: 24590871PAPER Jiang S, Li Y, Zhang C, Zhao Y, Bu G, Xu H, Zhang YW
M1 muscarinic acetylcholine receptor in Alzheimer's disease.
Neurosci Bull. 2014 Apr;30(2):295-307. Epub 2014 Mar 3 PubMed: 24590577PAPER Yadav RS, Tiwari NK
Lipid Integration in Neurodegeneration: An Overview of Alzheimer's Disease.
Mol Neurobiol. 2014 Mar 5; PubMed: 24590317PAPER Brosch JR, Matthews BR
Journal Club: comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology.
Neurology. 2014 Mar 4;82(9):e76-8. PubMed: 24590252PAPER Prokic I, Cowling BS, Laporte J
Amphiphysin 2 (BIN1) in physiology and diseases.
J Mol Med (Berl). 2014 May;92(5):453-63. Epub 2014 Mar 5 PubMed: 24590001PAPER Fonseca AC, Oliveira CR, Pereira CF, Cardoso SM
Loss of proteostasis induced by amyloid beta peptide in brain endothelial cells.
Biochim Biophys Acta. 2014 Jun;1843(6):1150-61. Epub 2014 Feb 28 PubMed: 24589617PAPER Wang W, Yang L, Tan L, Wu X, Jiang B, Shen X
Arg972 insulin receptor substrate-1 polymorphism and risk and severity of Alzheimer's disease.
J Clin Neurosci. 2014 Jul;21(7):1233-7. Epub 2013 Dec 19 PubMed: 24589556PAPER Qiang X, Sang Z, Yuan W, Li Y, Liu Q, Bai P, Shi Y, Ang W, Tan Z, Deng Y
Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease.
Eur J Med Chem. 2014 Apr 9;76:314-31. Epub 2014 Feb 17 PubMed: 24589487PAPER Lim YY, Maruff P, Pietrzak RH, Ellis KA, Darby D, Ames D, Harrington K, Martins RN, Masters CL, Szoeke C, Savage G, Villemagne VL, Rowe CC, AIBL Research Group
Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease.
Alzheimers Dement. 2014 Feb 28; PubMed: 24589436Current Filters
No filters selected